Eurofins (via Eurofins Clinical Testing Lux) Acquires Genetic Testing Service JSC (Gentis) in Vietnam
February 9, 2022
Eurofins Scientific, through its subsidiary Eurofins Clinical Testing Lux Sarl, has acquired Genetic Testing Service JSC (Gentis), a market leader in specialised genetic testing in Vietnam. The deal expands Eurofins' footprint in Southeast Asia and strengthens its clinical genetics and advanced molecular diagnostics capabilities in the region.
- Buyers
- Eurofins Scientific SE, Eurofins Clinical Testing Lux Sarl
- Targets
- Genetic Testing Service JSC (Gentis)
- Industry
- Healthcare Services
- Location
- Hanoi, Vietnam
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Eurofins Acquires Genetic Testing Service JSC (Gentis) in Vietnam
February 9, 2022
Healthcare Services
Eurofins Scientific, via its subsidiary Eurofins Clinical Testing Lux Sarl, has acquired Genetic Testing Service JSC (Gentis), a leading provider of specialised genetic and clinical testing in Vietnam. The acquisition expands Eurofins' clinical diagnostics footprint in Southeast Asia and adds Gentis' genetic testing capabilities and customer relationships with hospitals and consumers.
-
Eurofins Acquires DNA Diagnostics Center from GHO Capital
June 28, 2021
Healthcare Services
Eurofins, the publicly traded global laboratory testing group, has agreed to acquire DNA Diagnostics Center (DDC), a consumer-focused DNA testing company based in Fairfield, Ohio, from GHO Capital. DDC, which has approximately 240 employees and a broad portfolio of at‑home and lab-based DNA tests, will join Eurofins to expand its consumer genetics and health & wellness testing capabilities and global reach.
-
Eurofins Scientific Acquires Infinity Laboratories
September 16, 2024
Healthcare Services
Eurofins Scientific has completed the acquisition of Infinity Laboratories, a U.S.-based contract testing group that operates eight laboratories and employs approximately 100 staff. The deal expands Eurofins' microbiology and package testing footprint across the United States, enhancing its BioPharma and Medical Device testing capabilities and geographic coverage.
-
Eurofins Scientific Acquires Majority Stake in LifeCodexx
July 27, 2017
Biotechnology
Eurofins Scientific has acquired a 62.63% stake in LifeCodexx AG from GATC Biotech AG, strengthening Eurofins' non-invasive prenatal testing (NIPT) capabilities. LifeCodexx, headquartered in Constance, Germany, is a developer of the PrenaTest NIPT and generated approximately EUR 7m in revenue in 2016.
-
Eurofins Scientific Acquires bioskin GmbH
August 4, 2021
Healthcare Services
Eurofins Scientific has completed the acquisition of bioskin GmbH, a Hamburg-based dermatology-focused CRO that provides clinical trials for drugs, medical devices, food supplements and advanced cosmetics. The deal expands Eurofins' clinical study management and dermatology capabilities in Germany and strengthens its Cosmetics & Personal Care testing offering.
-
Solvias Acquires Cergentis
July 13, 2022
Biotechnology
Swiss analytical contract research and manufacturing company Solvias acquired Utrecht-based genomics services provider Cergentis on July 12, 2022. The deal adds Cergentis' proprietary Targeted Locus Amplification (TLA) genomic analysis capabilities to Solvias' biologics and cell & gene therapy testing platform to expand its advanced-therapy testing services globally.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.